Factor XI, human

Antibody	Host	Catalogue No.	Size	Product Insert
Purified IgG	Goat	GAFXI-IG	5 mg
Affinity purified IgG	Goat	GAFXI-AP	0.5 mg
Peroxidase conjugated IgG	Goat	GAFXI-HRP	0.2 mg
Affinity purified, FITC conjugated IgG	Goat	GAFXI-APFTC	0.1 mg
Affinity purified, biotinylated IgG	Goat	GAFXI-APBIO	0.1 mg
Purified IgG	Sheep	SAFXI-IG	5 mg
Affinity purified IgG	Sheep	SAFXI-AP	0.5 mg
Matched Pair Antibodies for EIA		FXI-EIA	5 plates

Description of Factor XI (FXI)

Factor XI (FXI, plasma thromboplastin antecedent) is a coagulation protein produced in the liver that circulates in plasma at approximately 5 μg/mL (30 nM). The mass of FXI is 160 kDa as determined by SDS-PAGE under non-reducing conditions and 80 kDa upon reduction. FXI consists of two identical 80 kDa subunits linked by disulphide bonds. Each subunit consists of a tandem repeat of four apple domains followed by a serine protease catalytic domain. Cleavage of FXI by activated factor XII or thrombin converts each subunit into a two-chain form and generates two active sites per FXIa molecule. The mass of FXIa is 160 kDa unreduced, but upon reduction FXIa migrates as a heavy chain of 50 kDa and a light chain of 30 kDa. The catalytic site of FXIa resides in the light chain. In plasma, FXI or FXIa circulates in non-covalent 1:1 complex with high molecular weight kininogen, which acts as a cofactor in the activation of FXI by activated factor XII. The activity of FXIa is regulated by platelets and by several proteinase inhibitors including, in order of decreasing importance, C1-inhibitor, α2antiplasmin, α1antitrypsin and antithrombin. Heparin has relatively little effect on the rate of inhibition of FXIa by antithrombin. The only known natural substrate for activated FXI (FXIa) is factor IX (Christmas factor) and the only cofactor required for this reaction is ionized calcium^1-3.

References:

1. Wuillemin WA, Minnema M, Meijers JCM, Roem D, Erenberg AJM, Nuijens JH, ten Cate H, Hack EC; Inactivation of Factor XIa in Human Plasma Assessed by Measuring Factor XIa-Protease Inhibitor Complexes: Major Role for C1-Inhibitor. Blood 85:1517, 1995.

2. DeLa Cadena R, Watchtfogel YT, Colman RW, in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 219-240, J.B. Lippincott Co., Philadelphia, 1994.

3. Baglia FA, Seaman FS, Walsh, PN; The Apple 1 and 4 domains of Factor XI Act to Synergistically Promote the Surface-Mediated Activation of Factor XI by Factor XIIa. Blood 85:2078, 1995.

Related Products:

GAFXI-IG Goat anti-human FXI, whole IgG from antiserum

GAFXI-AP Goat anti-human FXI, affinity-purified IgG

GAFXI-HRP Goat anti-human FXI, IgG-peroxidase conjugate

SAFXI-IG Sheep anti-human FXI, IgG from antiserum

SAFXI-AP Sheep anti-human FXI, affinity purified IgG

FXI-EIA Paired antibody set for ELISA of FXI, 5 x 96 wells

FXI-DP Human plasma deficient in FXI, immune depleted

INH11-DP Factor XI Inhibitor Plasma, Frozen

INH11-LDP Factor XI Inhibitor Plasma, Lyophilized